Tif1γ expression has shown to be decreased in pancreatic ductal adenocarcinomas with the use of RT-PCR and immunohistochemistry [84] Tif1γ inactivation in the presence of activated Kras mutation can result in cystic pancreatic tumors in the mouse model [84]. This evidence concerns the gene TRIM33 and pancreatic ductal adenocarcinoma.